2020
DOI: 10.1007/s11060-020-03396-w
|View full text |Cite
|
Sign up to set email alerts
|

Current status and treatment modalities in metastases to the pituitary: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
56
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(56 citation statements)
references
References 36 publications
0
56
0
Order By: Relevance
“…The pituitary gland can be involved by metastatic lesions via the skull base, hematogenous, or meningeal spread [ 8 ]. According to a recent systematic review, the pituitary metastases (PM) are uncommon, accounting for 0.4% of intracranial metastases [ 9 ]. Almost every cancer is reported having a potential source for sellar metastasis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The pituitary gland can be involved by metastatic lesions via the skull base, hematogenous, or meningeal spread [ 8 ]. According to a recent systematic review, the pituitary metastases (PM) are uncommon, accounting for 0.4% of intracranial metastases [ 9 ]. Almost every cancer is reported having a potential source for sellar metastasis.…”
Section: Introductionmentioning
confidence: 99%
“…PM has a poor prognosis and the management of patients with PM is palliative. The diagnosis of such malignancies is challenging because patients mostly presented nonspecific signs that could overshadow symptoms of hypopituitarism or diabetes insipidus, so the diagnosis is ultimately confirmed by histopathology [ 9 , 12 ]. Sellar masses are rarely constituted by infiltrative neoplasm (such as lymphoma), inflammatory and granulomatous diseases of the pituitary [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…Patients with PM present in ∼50% of the cases with diabetes insipidus [4][5][6][7][8][9], which rarely occurs in patients with pituitary adenomas. Other symptoms and signs include visual damage (30%), ophthalmoplegia (25%), headache/retroorbital pain (20%), and also fatigue, weight loss, nausea/vomiting, and cognitive deterioration in 5-10% of the affected subjects [4][5][7][8].…”
Section: Symptoms At Presentationmentioning
confidence: 99%
“…Other symptoms and signs include visual damage (30%), ophthalmoplegia (25%), headache/retroorbital pain (20%), and also fatigue, weight loss, nausea/vomiting, and cognitive deterioration in 5-10% of the affected subjects [4][5][7][8]. Anterior pituitary deficiency is reported in 25-45% of the cases [4][5][6][7][8][9] with central hypothyroidism and low cortisol levels identified frequently. Hyperprolactinemia is depicted in 80% of the patients with PMs [8].…”
Section: Symptoms At Presentationmentioning
confidence: 99%
See 1 more Smart Citation